Department of Medicine, Section of Infectious Diseases, Boston Medical Center, Boston, MA, United States of America.
Department of Internal Medicine, Health Economics and Epidemiology Research Office, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
PLoS One. 2023 Mar 14;18(3):e0280748. doi: 10.1371/journal.pone.0280748. eCollection 2023.
Many sub-Saharan Africa countries are scaling up differentiated service delivery (DSD) models for HIV treatment to increase access and remove barriers to care. We assessed factors associated with attrition after DSD model enrollment in Zambia, focusing on patient-level characteristics.
We conducted a retrospective record review using electronic medical records (EMR) of adults (≥15 years) initiated on antiretroviral (ART) between 01 January 2018 and 30 November 2021. Attrition was defined as lost to follow-up (LTFU) or died by November 30, 2021. We categorized DSD models into eight groups: fast-track, adherence groups, community pick-up points, home ART delivery, extended facility hours, facility multi-month dispensing (MMD, 4-6-month ART dispensing), frequent refill care (facility 1-2 month dispensing), and conventional care (facility 3 month dispensing, reference group). We used Fine and Gray competing risk regression to assess patient-level factors associated with attrition, stratified by sex and rural/urban setting.
Of 547,281 eligible patients, 68% (n = 372,409) enrolled in DSD models, most commonly facility MMD (n = 306,430, 82%), frequent refill care (n = 47,142, 13%), and fast track (n = 14,433, 4%), with <2% enrolled in the other DSD groups. Retention was higher in nearly all DSD models for all dispensing intervals, compared to the reference group, except fast track for the ≤2 month dispensing group. Retention benefits were greatest for patients in the extended clinic hours group and least for fast track dispensing.
Although retention in HIV treatment differed by DSD type, dispensing interval, and patient characteristics, nearly all DSD models out-performed conventional care. Understanding the factors that influence the retention of patients in DSD models could provide an important step towards improving DSD implementation.
许多撒哈拉以南非洲国家正在扩大差异化服务提供 (DSD) 模式以治疗艾滋病毒,以增加获得治疗的机会并消除护理障碍。我们评估了赞比亚在 DSD 模式登记后患者流失的相关因素,重点关注患者的特征。
我们使用电子病历 (EMR) 对 2018 年 1 月 1 日至 2021 年 11 月 30 日期间开始接受抗逆转录病毒治疗 (ART) 的成年人(≥15 岁)进行了回顾性记录审查。失访(LTFU)或在 2021 年 11 月 30 日前死亡定义为流失。我们将 DSD 模式分为八组:快速通道、依从性组、社区取药点、上门 ART 配送、延长医疗机构工作时间、机构多剂量配药(4-6 个月 ART 配药)、频繁续药护理(机构 1-2 个月配药)和常规护理(机构 3 个月配药,参照组)。我们使用 Fine 和 Gray 竞争风险回归评估了与流失相关的患者特征,按性别和城乡环境进行分层。
在 547,281 名合格患者中,68%(n = 372,409)参加了 DSD 模式,最常见的是机构多剂量配药模式(n = 306,430,82%)、频繁续药护理模式(n = 47,142,13%)和快速通道模式(n = 14,433,4%),其他 DSD 模式的入组比例均<2%。与参照组相比,在所有配药间隔中,几乎所有 DSD 模式的保留率都更高,除了≤2 个月配药组的快速通道模式。在延长门诊时间组中,保留受益最大,而在快速通道配药组中受益最小。
尽管 DSD 类型、配药间隔和患者特征对 HIV 治疗的保留率有影响,但几乎所有 DSD 模式都优于常规护理。了解影响 DSD 模式患者保留率的因素可能是改善 DSD 实施的重要一步。